Predictive oncology stock.

Charles Nuzum POAI stock SEC Form 4 insiders trading. Charles has made over 1 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently Charles bought 200,000 units of POAI stock worth $62,000 on 20 May 2022.200,000 units of POAI stock worth $62,000 on 20 May 2022.The estimated Net Worth of J Melville Engle is at least $117 millier dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $113,900 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.Latest company newsPredictive Oncology forms a strategic partnership that has the potential to revolutionize the field of radiation oncology. Digital newsroomLinks to …The first split for POAI took place on October 29, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of POAI owned pre-split, the shareholder ...

Predictive Oncology (Nasdaq:POAI) - Stock Price, News & Analysis - Simply Wall St Stocks / United States / Healthcare Predictive Oncology …0.73%. $39.94B. Astellas Pharma Inc. -4.37%. ¥3.42T. PYXS | Complete Pyxis Oncology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that it has completed a multi-year study ...

Latest company newsPredictive Oncology forms a strategic partnership that has the potential to revolutionize the field of radiation oncology. Digital newsroomLinks to …The estimated Net Worth of Daniel E Handley is at least $351 Thousand dollars as of 15 December 2022. Daniel Handley owns over 6,000 units of Predictive Oncology stock worth over $350,584 and over the last 3 years he sold POAI stock worth over $0. In addition, he makes $0 as Director at Predictive Oncology.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Predictive Oncology share forecasts, stock quote and buy / sell signals below. According to present data Predictive Oncology's POAI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Predictive Oncology's common stock will continue to be traded on the Nasdaq Capital Market under the symbol POAI and will begin trading on a split-adjusted ...The next two stocks on this list of AI penny stocks with huge potential combine the benefits of AI with biotechnology. And both have similar missions. The first of these is Predictive Oncology ...The reverse stock split will reduce the number of shares of Predictive Oncology’s common stock outstanding from 79,597,181 shares to approximately 3,979,860 shares, subject to adjustment for the ...

Nov 17, 2023 · finance.yahoo.com - March 21 at 3:52 PM. Predictive Oncology Inc.: Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock. finanznachrichten.de - March 17 at 10:22 AM. Predictive Oncology and Cancer Research Horizons partner up to pursue development of cancer drugs.

Nov 13, 2023 · POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35...

Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ...Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Predictive Oncology Pharmaceutical Manufacturing Pittsburgh, PA 1,638 followers Predictive Oncology (NASDAQ:POAI) offers a suite of solutions for oncology drug development from discovery to trials.Overview Press Releases Events & Presentations Financials & Filings Stock Quote & Chart Corporate Governance Contact Us Stock Quote (POAI) NASDAQ CM: POAI $3.17 Oct 2, 2023 4:00 PM EDT Change 0 (0.00%) Volume 0 Today's Open -- Previous Close $3.17 Today's High $3.20 Today's Low $3.07 52 Week High $13.88 52 Week Low $2.47 Stock Chart Here are three artificial intelligence stocks that could be acquired. SoundHound ( AI ): The company is exposed to a $500 million a year opportunity with autos and restaurants. Predictive Oncology ...

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comHere are three artificial intelligence stocks that could be acquired. SoundHound ( AI ): The company is exposed to a $500 million a year opportunity with autos and restaurants. Predictive Oncology ...ETFs positionnés sur Predictive Oncology Inc. Nom, Poids, Encours, Varia. 1 janv. Note Invest. VANGUARD TOTAL STOCK MARKET ...FOSTER CITY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company …Real-time quotes, advanced visualizations, historical statements, and much more. Selling, General and Administrative Excl. Other. POAI - Predictive Oncology Inc - Stock screener for investors and traders, financial visualizations.Find the latest Predictive Oncology Inc. (POAI) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Clovis Oncology (NASDAQ:CLVS) issued its quarterly earnings data on Wednesday, November, 3rd. The biopharmaceutical company reported ($0.56) earnings per share for the quarter, missing analysts' consensus estimates of ($0.48) by $0.08. The biopharmaceutical company had revenue of $37.92 million for the quarter, compared to …Find real-time POAI - Predictive Oncology Inc stock quotes, company profile, news and forecasts from CNN Business.

Shares of Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.95 and traded ...Predictive Oncology Inc stock performance at a glance. Check Predictive Oncology Inc’s past financial performance, like revenue or net income, plus the top level summary of its …The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of …Shares of Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.95 and traded ...Predictive Oncology (NASDAQ:POAI) on Thursday said it would effect a 1-for-20 reverse stock split.The stock split will become effective on April 24. "The reverse stock split is primarily intended ...Predictive Oncology Pharmaceutical Manufacturing Pittsburgh, PA 1,638 followers Predictive Oncology (NASDAQ:POAI) offers a suite of solutions for oncology drug development from discovery to trials.Admittedly, Gilead is starting from scratch in oncology, with only three approved products - for context, Bristol Myers Squibb markets and sells 9 major oncology products, which will likely drive ...

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ...

Predictive Oncology (POAI) Quote Overview ... It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Apr 20, 2023 · Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre-split shares. EAGAN, Minn., March 30, 2023 -- Predictive Oncology , a science-driven company on the leading edge of oncology drug discovery and development, today announces it is partnering with Integra... 913b.o1cVR7gyXoAeqM__EZxN8wwGZbaw1v-dIxac9ajTj9U.9zVmMfZ_M_hIwf-nVe41oEVNC-adl8uqcnDxo9-y7LDOIVEewlAO803fjgFind the latest historical data for Predictive Oncology Inc. Common Stock (POAI) at Nasdaq.com.According to the issued ratings of 5 analysts in the last year, the consensus rating for Pyxis Oncology stock is Buy based on the current 5 buy ratings for PYXS. The average twelve-month price prediction for Pyxis Oncology is $8.33 with a high price target of $14.00 and a low price target of $4.00. Learn more on PYXS's analyst rating history.The Predictive Oncology Inc ( POAI) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $5.0628, representing a +68.20% increase from the current price of $3.01. The highest analyst price target is $9.9664, and the lowest is $0.1593. Based on our technical indicators, the current sentiment ...Based on 79,403,893 shares of common stock issued and outstanding as of March 17, 2023, immediately following the Reverse Stock Split, the Company would have approximately 39,701,947 shares of common stock issued and outstanding (without giving effect to rounding for fractional shares) if the ratio for the Reverse Stock Split is one-for- …Nov 17, 2023 · finance.yahoo.com - March 21 at 3:52 PM. Predictive Oncology Inc.: Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock. finanznachrichten.de - March 17 at 10:22 AM. Predictive Oncology and Cancer Research Horizons partner up to pursue development of cancer drugs. Discover historical prices for POAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Predictive Oncology Inc. stock was issued. Predictive Oncology Inc. (POAI) Stock Price | Stock Quote Nasdaq - MarketScreener PREDICTIVE ONCOLOGY INC. Predictive Oncology Inc. Stock price …POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35...

View the latest Predictive Oncology Inc. (POAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.Predictive Oncology. POAI. $3.09 ... as of November 29 4:00:00 PM EST. Predictive Oncology (POAI) Stock Price Performance. Predictive Oncology (POAI) Stock Key Data. Summary Additional Data ... Here are three top AI stocks trading under $10 a share. Lantern Pharma Inc. ( LTRN ): A small, potential game-changer in the fight against cancer. Predictive Oncology (POAI): While risky, POAI ...Instagram:https://instagram. apple dividends historysaga falabella lima peruphppynorfolk southern stocks Tesla’s stock is predicted to increase in value in 2015, according to Forbes. In January 2015, Forbes noted that Tesla Motors, Inc.Predictive Oncology Inc. (POAI) is a science-driven company that leverages its AI and machine learning capabilities to accelerate oncologic drug discovery and enable drug development. The stock price, news, quote and history of POAI are shown on Yahoo Finance, as well as related research and analysis. hcti newsoptions volume scanner The estimated Net Worth of Richard L Gabriel is at least $58.5 Thousand dollars as of 1 September 2020. Mr Gabriel owns over 4,000 units of Predictive Oncology stock worth over $56,126 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $2,333 as Sr. VP of R&D at Predictive Oncology.Predictive Oncology. Price today: US$0.4308. Market cap: US$33.671 million. Predictive Oncology is a company that is focused on the use of data and artificial intelligence to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcomes. faraday electric car Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Institutional investors purchased a net $136.9 thousand shares of POAI during the quarter ended March 2019, and now own 9.41% of the total float, a percentage ...